AgingResearch.NewsJoin free

Daratumumab

Intervention

2 papers study it

MeSH

Across all fields, 2 papers: 1 observational study in people, 1 in cells

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

About aging: trials about aging, of every trial that tests the drug for any use.

No results posted: trials that ended over a year ago with no results on ClinicalTrials.gov and no paper reporting them.

  • 20 trials, none about aging, 1 with no results posted
  • Humans1
  • Cells1

Development

Companies
  • Regeneron PharmaceuticalsPhase 3high risk smoldering multiple myeloma
  • Janssen Research & DevelopmentPhase 3multiple myeloma, precursor cell lymphoblastic leukemia lymphoma
  • AbbViePhase 2/3multiple myeloma

Trial sponsors

Latest

Related